nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—Hypothyroidism—Thiotepa—sarcoma	0.0174	0.0174	CcSEcCtD
Gallamine Triethiodide—Cyst—Thiotepa—sarcoma	0.0167	0.0167	CcSEcCtD
Gallamine Triethiodide—Leukaemia—Epirubicin—sarcoma	0.0167	0.0167	CcSEcCtD
Gallamine Triethiodide—Leukaemia—Doxorubicin—sarcoma	0.0154	0.0154	CcSEcCtD
Gallamine Triethiodide—Bone marrow depression—Vincristine—sarcoma	0.0147	0.0147	CcSEcCtD
Gallamine Triethiodide—Bone marrow depression—Mitoxantrone—sarcoma	0.0143	0.0143	CcSEcCtD
Gallamine Triethiodide—Endocrine disorder—Thiotepa—sarcoma	0.0135	0.0135	CcSEcCtD
Gallamine Triethiodide—Neoplasm malignant—Thiotepa—sarcoma	0.0131	0.0131	CcSEcCtD
Gallamine Triethiodide—Numbness—Vincristine—sarcoma	0.0119	0.0119	CcSEcCtD
Gallamine Triethiodide—Sensory loss—Vincristine—sarcoma	0.0114	0.0114	CcSEcCtD
Gallamine Triethiodide—Tingling sensation—Etoposide—sarcoma	0.00998	0.00998	CcSEcCtD
Gallamine Triethiodide—Numbness—Etoposide—sarcoma	0.00968	0.00968	CcSEcCtD
Gallamine Triethiodide—Sensory loss—Etoposide—sarcoma	0.00926	0.00926	CcSEcCtD
Gallamine Triethiodide—Swelling—Mitoxantrone—sarcoma	0.00793	0.00793	CcSEcCtD
Gallamine Triethiodide—Polyp—Epirubicin—sarcoma	0.00739	0.00739	CcSEcCtD
Gallamine Triethiodide—Eruption—Epirubicin—sarcoma	0.00731	0.00731	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Mitoxantrone—sarcoma	0.007	0.007	CcSEcCtD
Gallamine Triethiodide—Polyp—Doxorubicin—sarcoma	0.00684	0.00684	CcSEcCtD
Gallamine Triethiodide—Eruption—Doxorubicin—sarcoma	0.00676	0.00676	CcSEcCtD
Gallamine Triethiodide—Cyst—Epirubicin—sarcoma	0.00673	0.00673	CcSEcCtD
Gallamine Triethiodide—Bone marrow depression—Epirubicin—sarcoma	0.00666	0.00666	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Thiotepa—sarcoma	0.00665	0.00665	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Dactinomycin—sarcoma	0.0066	0.0066	CcSEcCtD
Gallamine Triethiodide—Swelling—Etoposide—sarcoma	0.0066	0.0066	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Mitoxantrone—sarcoma	0.00639	0.00639	CcSEcCtD
Gallamine Triethiodide—Cyst—Doxorubicin—sarcoma	0.00622	0.00622	CcSEcCtD
Gallamine Triethiodide—Bone marrow depression—Doxorubicin—sarcoma	0.00616	0.00616	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Vincristine—sarcoma	0.0059	0.0059	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Mitoxantrone—sarcoma	0.00575	0.00575	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Thiotepa—sarcoma	0.00564	0.00564	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Thiotepa—sarcoma	0.00561	0.00561	CcSEcCtD
Gallamine Triethiodide—Blood disorder—Epirubicin—sarcoma	0.00538	0.00538	CcSEcCtD
Gallamine Triethiodide—Neoplasm malignant—Epirubicin—sarcoma	0.00527	0.00527	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Thiotepa—sarcoma	0.00524	0.00524	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Thiotepa—sarcoma	0.0052	0.0052	CcSEcCtD
Gallamine Triethiodide—Blood disorder—Doxorubicin—sarcoma	0.00498	0.00498	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Vincristine—sarcoma	0.00495	0.00495	CcSEcCtD
Gallamine Triethiodide—Neoplasm malignant—Doxorubicin—sarcoma	0.00487	0.00487	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Mitoxantrone—sarcoma	0.00487	0.00487	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Mitoxantrone—sarcoma	0.00485	0.00485	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Mitoxantrone—sarcoma	0.00484	0.00484	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Etoposide—sarcoma	0.00478	0.00478	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Vincristine—sarcoma	0.00461	0.00461	CcSEcCtD
Gallamine Triethiodide—Anaemia—Thiotepa—sarcoma	0.00451	0.00451	CcSEcCtD
Gallamine Triethiodide—Anaemia—Dactinomycin—sarcoma	0.00448	0.00448	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Thiotepa—sarcoma	0.00437	0.00437	CcSEcCtD
Gallamine Triethiodide—Malaise—Dactinomycin—sarcoma	0.00437	0.00437	CcSEcCtD
Gallamine Triethiodide—Salivary hypersecretion—Epirubicin—sarcoma	0.00437	0.00437	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Dactinomycin—sarcoma	0.00434	0.00434	CcSEcCtD
Gallamine Triethiodide—Cough—Thiotepa—sarcoma	0.00426	0.00426	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Thiotepa—sarcoma	0.00416	0.00416	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Mitoxantrone—sarcoma	0.00413	0.00413	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00413	0.00413	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Epirubicin—sarcoma	0.00407	0.00407	CcSEcCtD
Gallamine Triethiodide—Salivary hypersecretion—Doxorubicin—sarcoma	0.00404	0.00404	CcSEcCtD
Gallamine Triethiodide—Confusional state—Thiotepa—sarcoma	0.00402	0.00402	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Etoposide—sarcoma	0.00401	0.00401	CcSEcCtD
Gallamine Triethiodide—Anaemia—Vincristine—sarcoma	0.004	0.004	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Thiotepa—sarcoma	0.0039	0.0039	CcSEcCtD
Gallamine Triethiodide—Anaemia—Mitoxantrone—sarcoma	0.0039	0.0039	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Thiotepa—sarcoma	0.00389	0.00389	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Vincristine—sarcoma	0.00387	0.00387	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Dactinomycin—sarcoma	0.00387	0.00387	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Thiotepa—sarcoma	0.00387	0.00387	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Epirubicin—sarcoma	0.00383	0.00383	CcSEcCtD
Gallamine Triethiodide—Malaise—Mitoxantrone—sarcoma	0.0038	0.0038	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Mitoxantrone—sarcoma	0.00377	0.00377	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Etoposide—sarcoma	0.00376	0.00376	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Doxorubicin—sarcoma	0.00376	0.00376	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Etoposide—sarcoma	0.00374	0.00374	CcSEcCtD
Gallamine Triethiodide—Cough—Mitoxantrone—sarcoma	0.00368	0.00368	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00363	0.00363	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.0036	0.0036	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Mitoxantrone—sarcoma	0.00359	0.00359	CcSEcCtD
Gallamine Triethiodide—Chest pain—Mitoxantrone—sarcoma	0.00359	0.00359	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Thiotepa—sarcoma	0.00358	0.00358	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Doxorubicin—sarcoma	0.00354	0.00354	CcSEcCtD
Gallamine Triethiodide—Confusional state—Mitoxantrone—sarcoma	0.00347	0.00347	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Vincristine—sarcoma	0.00346	0.00346	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Thiotepa—sarcoma	0.00344	0.00344	CcSEcCtD
Gallamine Triethiodide—Fatigue—Thiotepa—sarcoma	0.00343	0.00343	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Etoposide—sarcoma	0.00343	0.00343	CcSEcCtD
Gallamine Triethiodide—Fatigue—Dactinomycin—sarcoma	0.00341	0.00341	CcSEcCtD
Gallamine Triethiodide—Pain—Thiotepa—sarcoma	0.00341	0.00341	CcSEcCtD
Gallamine Triethiodide—Pain—Dactinomycin—sarcoma	0.00338	0.00338	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Mitoxantrone—sarcoma	0.00337	0.00337	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Mitoxantrone—sarcoma	0.00336	0.00336	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Mitoxantrone—sarcoma	0.00334	0.00334	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Thiotepa—sarcoma	0.00328	0.00328	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.00326	0.00326	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Dactinomycin—sarcoma	0.00326	0.00326	CcSEcCtD
Gallamine Triethiodide—Anaemia—Etoposide—sarcoma	0.00324	0.00324	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Vincristine—sarcoma	0.00322	0.00322	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Vincristine—sarcoma	0.00317	0.00317	CcSEcCtD
Gallamine Triethiodide—Urticaria—Thiotepa—sarcoma	0.00316	0.00316	CcSEcCtD
Gallamine Triethiodide—Malaise—Etoposide—sarcoma	0.00316	0.00316	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Thiotepa—sarcoma	0.00315	0.00315	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Thiotepa—sarcoma	0.00315	0.00315	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Etoposide—sarcoma	0.00314	0.00314	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00313	0.00313	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Dactinomycin—sarcoma	0.00313	0.00313	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Dactinomycin—sarcoma	0.00313	0.00313	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Mitoxantrone—sarcoma	0.00309	0.00309	CcSEcCtD
Gallamine Triethiodide—Cough—Etoposide—sarcoma	0.00306	0.00306	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Vincristine—sarcoma	0.00305	0.00305	CcSEcCtD
Gallamine Triethiodide—Fatigue—Vincristine—sarcoma	0.00305	0.00305	CcSEcCtD
Gallamine Triethiodide—Pain—Vincristine—sarcoma	0.00302	0.00302	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.00302	0.00302	CcSEcCtD
Gallamine Triethiodide—Chest pain—Etoposide—sarcoma	0.00299	0.00299	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Epirubicin—sarcoma	0.00298	0.00298	CcSEcCtD
Gallamine Triethiodide—Fatigue—Mitoxantrone—sarcoma	0.00297	0.00297	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00296	0.00296	CcSEcCtD
Gallamine Triethiodide—Pain—Mitoxantrone—sarcoma	0.00294	0.00294	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Thiotepa—sarcoma	0.00294	0.00294	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Epirubicin—sarcoma	0.00292	0.00292	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Dactinomycin—sarcoma	0.00291	0.00291	CcSEcCtD
Gallamine Triethiodide—Confusional state—Etoposide—sarcoma	0.00289	0.00289	CcSEcCtD
Gallamine Triethiodide—Asthenia—Thiotepa—sarcoma	0.00286	0.00286	CcSEcCtD
Gallamine Triethiodide—Asthenia—Dactinomycin—sarcoma	0.00284	0.00284	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Mitoxantrone—sarcoma	0.00284	0.00284	CcSEcCtD
Gallamine Triethiodide—Pruritus—Thiotepa—sarcoma	0.00282	0.00282	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Etoposide—sarcoma	0.0028	0.0028	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Etoposide—sarcoma	0.00279	0.00279	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Epirubicin—sarcoma	0.00279	0.00279	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Vincristine—sarcoma	0.00279	0.00279	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Vincristine—sarcoma	0.00279	0.00279	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Etoposide—sarcoma	0.00278	0.00278	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Doxorubicin—sarcoma	0.00276	0.00276	CcSEcCtD
Gallamine Triethiodide—Urticaria—Mitoxantrone—sarcoma	0.00273	0.00273	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Thiotepa—sarcoma	0.00273	0.00273	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Mitoxantrone—sarcoma	0.00272	0.00272	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Mitoxantrone—sarcoma	0.00272	0.00272	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Dactinomycin—sarcoma	0.00271	0.00271	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Doxorubicin—sarcoma	0.0027	0.0027	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Epirubicin—sarcoma	0.00268	0.00268	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Vincristine—sarcoma	0.0026	0.0026	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Doxorubicin—sarcoma	0.00258	0.00258	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Etoposide—sarcoma	0.00257	0.00257	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Mitoxantrone—sarcoma	0.00253	0.00253	CcSEcCtD
Gallamine Triethiodide—Asthenia—Vincristine—sarcoma	0.00253	0.00253	CcSEcCtD
Gallamine Triethiodide—Vomiting—Thiotepa—sarcoma	0.00253	0.00253	CcSEcCtD
Gallamine Triethiodide—Vomiting—Dactinomycin—sarcoma	0.00251	0.00251	CcSEcCtD
Gallamine Triethiodide—Rash—Thiotepa—sarcoma	0.00251	0.00251	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Thiotepa—sarcoma	0.00251	0.00251	CcSEcCtD
Gallamine Triethiodide—Headache—Thiotepa—sarcoma	0.0025	0.0025	CcSEcCtD
Gallamine Triethiodide—Rash—Dactinomycin—sarcoma	0.00249	0.00249	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Doxorubicin—sarcoma	0.00248	0.00248	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Etoposide—sarcoma	0.00247	0.00247	CcSEcCtD
Gallamine Triethiodide—Asthenia—Mitoxantrone—sarcoma	0.00247	0.00247	CcSEcCtD
Gallamine Triethiodide—Fatigue—Etoposide—sarcoma	0.00247	0.00247	CcSEcCtD
Gallamine Triethiodide—Pain—Etoposide—sarcoma	0.00245	0.00245	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Vincristine—sarcoma	0.00242	0.00242	CcSEcCtD
Gallamine Triethiodide—Nausea—Thiotepa—sarcoma	0.00237	0.00237	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Etoposide—sarcoma	0.00236	0.00236	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Mitoxantrone—sarcoma	0.00235	0.00235	CcSEcCtD
Gallamine Triethiodide—Nausea—Dactinomycin—sarcoma	0.00235	0.00235	CcSEcCtD
Gallamine Triethiodide—Urticaria—Etoposide—sarcoma	0.00227	0.00227	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Epirubicin—sarcoma	0.00227	0.00227	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Epirubicin—sarcoma	0.00226	0.00226	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Etoposide—sarcoma	0.00226	0.00226	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Etoposide—sarcoma	0.00226	0.00226	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Epirubicin—sarcoma	0.00226	0.00226	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Epirubicin—sarcoma	0.00225	0.00225	CcSEcCtD
Gallamine Triethiodide—Vomiting—Vincristine—sarcoma	0.00225	0.00225	CcSEcCtD
Gallamine Triethiodide—Rash—Vincristine—sarcoma	0.00223	0.00223	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Vincristine—sarcoma	0.00223	0.00223	CcSEcCtD
Gallamine Triethiodide—Headache—Vincristine—sarcoma	0.00221	0.00221	CcSEcCtD
Gallamine Triethiodide—Vomiting—Mitoxantrone—sarcoma	0.00219	0.00219	CcSEcCtD
Gallamine Triethiodide—Rash—Mitoxantrone—sarcoma	0.00217	0.00217	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Mitoxantrone—sarcoma	0.00217	0.00217	CcSEcCtD
Gallamine Triethiodide—Headache—Mitoxantrone—sarcoma	0.00216	0.00216	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Epirubicin—sarcoma	0.00211	0.00211	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Etoposide—sarcoma	0.00211	0.00211	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Doxorubicin—sarcoma	0.0021	0.0021	CcSEcCtD
Gallamine Triethiodide—Nausea—Vincristine—sarcoma	0.0021	0.0021	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Epirubicin—sarcoma	0.0021	0.0021	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Doxorubicin—sarcoma	0.00209	0.00209	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Doxorubicin—sarcoma	0.00209	0.00209	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Doxorubicin—sarcoma	0.00208	0.00208	CcSEcCtD
Gallamine Triethiodide—Asthenia—Etoposide—sarcoma	0.00205	0.00205	CcSEcCtD
Gallamine Triethiodide—Nausea—Mitoxantrone—sarcoma	0.00204	0.00204	CcSEcCtD
Gallamine Triethiodide—Pruritus—Etoposide—sarcoma	0.00202	0.00202	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Etoposide—sarcoma	0.00196	0.00196	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Doxorubicin—sarcoma	0.00195	0.00195	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Doxorubicin—sarcoma	0.00194	0.00194	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Epirubicin—sarcoma	0.00192	0.00192	CcSEcCtD
Gallamine Triethiodide—Vomiting—Etoposide—sarcoma	0.00182	0.00182	CcSEcCtD
Gallamine Triethiodide—Anaemia—Epirubicin—sarcoma	0.00182	0.00182	CcSEcCtD
Gallamine Triethiodide—Rash—Etoposide—sarcoma	0.0018	0.0018	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Etoposide—sarcoma	0.0018	0.0018	CcSEcCtD
Gallamine Triethiodide—Headache—Etoposide—sarcoma	0.00179	0.00179	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Doxorubicin—sarcoma	0.00178	0.00178	CcSEcCtD
Gallamine Triethiodide—Malaise—Epirubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Epirubicin—sarcoma	0.00176	0.00176	CcSEcCtD
Gallamine Triethiodide—Cough—Epirubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Gallamine Triethiodide—Nausea—Etoposide—sarcoma	0.0017	0.0017	CcSEcCtD
Gallamine Triethiodide—Anaemia—Doxorubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Gallamine Triethiodide—Chest pain—Epirubicin—sarcoma	0.00167	0.00167	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Epirubicin—sarcoma	0.00167	0.00167	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00166	0.00166	CcSEcCtD
Gallamine Triethiodide—Malaise—Doxorubicin—sarcoma	0.00164	0.00164	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Doxorubicin—sarcoma	0.00163	0.00163	CcSEcCtD
Gallamine Triethiodide—Confusional state—Epirubicin—sarcoma	0.00162	0.00162	CcSEcCtD
Gallamine Triethiodide—Cough—Doxorubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Epirubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Epirubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Epirubicin—sarcoma	0.00156	0.00156	CcSEcCtD
Gallamine Triethiodide—Chest pain—Doxorubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Doxorubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00154	0.00154	CcSEcCtD
Gallamine Triethiodide—Confusional state—Doxorubicin—sarcoma	0.0015	0.0015	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Doxorubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Doxorubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Doxorubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Epirubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Epirubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Gallamine Triethiodide—Fatigue—Epirubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Gallamine Triethiodide—Pain—Epirubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Doxorubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Epirubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Gallamine Triethiodide—Fatigue—Doxorubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Gallamine Triethiodide—Urticaria—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Gallamine Triethiodide—Pain—Doxorubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Doxorubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Gallamine Triethiodide—Urticaria—Doxorubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Doxorubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Doxorubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Gallamine Triethiodide—Asthenia—Epirubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Gallamine Triethiodide—Pruritus—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Epirubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Gallamine Triethiodide—Asthenia—Doxorubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Gallamine Triethiodide—Pruritus—Doxorubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Gallamine Triethiodide—Vomiting—Epirubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Gallamine Triethiodide—Rash—Epirubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Epirubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Gallamine Triethiodide—Headache—Epirubicin—sarcoma	0.001	0.001	CcSEcCtD
Gallamine Triethiodide—Nausea—Epirubicin—sarcoma	0.000953	0.000953	CcSEcCtD
Gallamine Triethiodide—Vomiting—Doxorubicin—sarcoma	0.000944	0.000944	CcSEcCtD
Gallamine Triethiodide—Rash—Doxorubicin—sarcoma	0.000936	0.000936	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Doxorubicin—sarcoma	0.000935	0.000935	CcSEcCtD
Gallamine Triethiodide—Headache—Doxorubicin—sarcoma	0.00093	0.00093	CcSEcCtD
Gallamine Triethiodide—Nausea—Doxorubicin—sarcoma	0.000882	0.000882	CcSEcCtD
